TheraRadar
← Back
Data updated: Mar 29, 2026

HERITAGE PHARMA

CardiovascularNeurologyOphthalmology
Generics

HERITAGE PHARMA is a generic drug manufacturer focused on Cardiovascular, Neurology, Ophthalmology.

1972
Since
38
Drugs
-
Trials
488
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

BUPROPION HYDROCHLORIDE 2026-02-25
Labeling
DOXYCYCLINE HYCLATE 2026-02-19
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
BUMETANIDE 2026-02-05
CETIRIZINE HYDROCHLORIDE ALLERGY 2026-01-30
Labeling
DOXYCYCLINE HYCLATE 2026-01-26
Labeling
DOXYCYCLINE HYCLATE 2026-01-20
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 62%
8 drugs
Neurology 15%
2 drugs
Ophthalmology 8%
1 drugs
Dermatology 8%
1 drugs
Immunology 8%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

BAUSCH specialty
Dermatology, Immunology, Ophthalmology, Cardiovascular
Novartis big-pharma
Cardiovascular, Immunology, Ophthalmology
BAUSCH AND LOMB specialty
Ophthalmology, Cardiovascular, Dermatology, Immunology
Baxter specialty
Cardiovascular, Dermatology, Ophthalmology
AbbVie big-pharma
Immunology, Neurology, Ophthalmology